ARTICLE | Product Development
Pfizer, BioNTech on track to make hundreds of millions of COVID-19 vaccine doses this year
Plus Vaxart’s vaccine selected for Warp Speed preclinical testing, and trio of vaccine manufacturing deals
June 26, 2020 10:27 PM UTC
Updated on Jun 27, 2020 at 1:09 AM UTC
Pfizer and its partner BioNTech could obtain emergency use authorization for a COVID-19 vaccine as early as October, and expect to be able to produce hundreds of millions of doses in 2020 and a billion doses in 2021, Albert Bourla, chairman and CEO of Pfizer, said Friday.
Pfizer’s news came the same day that Vaxart Inc. (NASDAQ:VXRT) said its vaccine had been selected for a preclinical study sponsored by the Trump administration’s Operation Warp Speed...